Notice2024-08285
National Cancer Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 18, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 76 (Thursday, April 18, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 76 (Thursday, April 18, 2024)]
[Notices]
[Pages 27771-27772]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-08285]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel SEP-13: NCI Clinical and Translational Cancer Research.
Date: May 22, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W102, Rockville, Maryland 20850 (Virtual
Meeting).
[[Page 27772]]
Contact Person: Shakeel Ahmad, Ph.D., Branch Chief, Research
Technology and Contract Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W102, Rockville, Maryland 20850, 240-276-6442,
<a href="/cdn-cgi/l/email-protection#2f4e47424e4b5c6f424e46430141464701484059"><span class="__cf_email__" data-cfemail="9cfdf4f1fdf8efdcf1fdf5f0b2f2f5f4b2fbf3ea">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Program Project (P01) Review SEP-E.
Date: June 18, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W240, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Hasan Siddiqui, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W240, Rockville, Maryland 20850 240-276-5122
<a href="/cdn-cgi/l/email-protection#cca4adbfada2e2bfa5a8a8a5bdb9a58ca2a5a4e2aba3ba"><span class="__cf_email__" data-cfemail="cda5acbeaca3e3bea4a9a9a4bcb8a48da3a4a5e3aaa2bb">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Prevention and Control Clinical Trials Planning.
Date: June 21, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W236, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Shuli Xia, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W236, Rockville, Maryland 20850 240-276-5256
<a href="/cdn-cgi/l/email-protection#4c3f243920256234252d0c222524622b233a"><span class="__cf_email__" data-cfemail="abd8c3dec7c285d3c2caebc5c2c385ccc4dd">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Pathway to Independence Award for Outstanding Early-Stage
Postdoctoral Researchers (K99/R00) and Mentored Research Scientist
Development Award (K01).
Date: June 24-25, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W238, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W238, Rockville, Maryland 20850, 240-276-7755,
<a href="/cdn-cgi/l/email-protection#8deff4e8e2e3eaa0eee5e8e1a3e1e8e8cde3e4e5a3eae2fb"><span class="__cf_email__" data-cfemail="05677c606a6b6228666d60692b696060456b6c6d2b626a73">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-2: NCI Clinical and Translational Cancer Research.
Date: June 27, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W242, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Zhiqiang Zou, M.D., Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W242, Rockville, Maryland 20850, 240-276-6372,
<a href="/cdn-cgi/l/email-protection#9ce6f3e9e6f4f5eddcf1fdf5f0b2f2f5f4b2fbf3ea"><span class="__cf_email__" data-cfemail="b7cdd8c2cddfdec6f7dad6dedb99d9dedf99d0d8c1">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-9: NCI Clinical and Translational Cancer Research.
Date: June 27, 2024.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850, 240-276-5460,
<a href="/cdn-cgi/l/email-protection#305a56515e57705d51595c1e5e59581e575f46"><span class="__cf_email__" data-cfemail="abc1cdcac5ccebc6cac2c785c5c2c385ccc4dd">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Cancer Biospecimen Review Meeting.
Date: June 28, 2024.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W236, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Shuli Xia, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W236, Rockville, Maryland 20850, 240-276-5256,
<a href="/cdn-cgi/l/email-protection#37445f425b5e194f5e5677595e5f19505841"><span class="__cf_email__" data-cfemail="f5869d80999cdb8d9c94b59b9c9ddb929a83">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Assay Validation of High-Quality Markers for Clinical
Studies.
Date: July 2, 2024.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850, 240-276-5460,
<a href="/cdn-cgi/l/email-protection#79131f18171e391418101557171011571e160f"><span class="__cf_email__" data-cfemail="7f15191e11183f121e16135111161751181009">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: April 15, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-08285 Filed 4-17-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 18, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.